Fulgent Genetics Files 8-K on Shareholder Matters

Ticker: FLGT · Form: 8-K · Filed: May 15, 2025 · CIK: 1674930

Fulgent Genetics, Inc. 8-K Filing Summary
FieldDetail
CompanyFulgent Genetics, Inc. (FLGT)
Form Type8-K
Filed DateMay 15, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, shareholder-vote

Related Tickers: FLGT

TL;DR

Fulgent Genetics (FLGT) filed an 8-K for shareholder vote matters. Nothing major disclosed yet.

AI Summary

Fulgent Genetics, Inc. filed an 8-K on May 15, 2025, to report on matters submitted to a vote of its security holders. The filing details the company's corporate actions and governance, as is standard for this type of report.

Why It Matters

This filing indicates that Fulgent Genetics held a shareholder vote, which is a key event for corporate governance and can signal changes in company direction or leadership.

Risk Assessment

Risk Level: low — This is a routine filing regarding shareholder votes and does not disclose any new material financial or operational information.

Key Players & Entities

  • Fulgent Genetics, Inc. (company) — Registrant
  • May 15, 2025 (date) — Filing Date

FAQ

What specific matters were submitted to a vote of Fulgent Genetics' security holders?

The filing indicates that matters were submitted to a vote, but the specific details of these matters are not provided in the excerpt.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on May 15, 2025.

What is Fulgent Genetics' principal executive office address?

Fulgent Genetics' principal executive office is located at 4399 Santa Anita Avenue, El Monte, California 91731.

What is Fulgent Genetics' telephone number?

Fulgent Genetics' telephone number is (626) 350-0537.

Under which section of the Securities Exchange Act is this 8-K filed?

This 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 15, 2025 regarding Fulgent Genetics, Inc. (FLGT).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.